findmyKOL
Clinical trialNCT04565275UnknownPhase 1, PHASE2Interventional

A Study of ICP-192 in Patients With Advanced Solid Tumors

SponsorBeijing InnoCare Pharma Tech Co., Ltd.Enrollment45Advanced Solid TumorsCholangiocarcinomaUrothelial Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Macquarie University Hospital

    Macquarie Park, New South Wales, Australia

    Recruiting
  • Genesiscare - North Shore

    St Leonards, New South Wales, Australia

    Recruiting
  • Westmead Hospital

    Westmead, New South Wales, Australia

    Recruiting
  • Pindara Private Hospital

    Benowa, Queensland, Australia

    Recruiting
  • Monash Medical Centre Clayton

    Clayton, Victoria, Australia

    Recruiting
  • Peninsula & South Eastern Haematology & Oncology Group

    Frankston, Victoria, Australia

    Recruiting
  • Olivia Newton-John Cancer Research Institute

    Melbourne, Victoria, Australia

    Recruiting
United States
  • Arizona Oncology

    Tucson, Arizona, United States

    Recruiting
  • University of California, San Diego (ucsd) - Moores Cancer Center

    La Jolla, California, United States

    Recruiting
  • Rocky Mountain Cancer Centers

    Aurora, Colorado, United States

    Recruiting
  • Mid Florida Hematology and Oncology

    Orange City, Florida, United States

    Not, yet, recruiting
  • Minnesota Oncology Hematology

    Minneapolis, Minnesota, United States

    Recruiting
  • Clinical Research Alliance

    Lake Success, New York, United States

    Recruiting
  • Rutgers Cancer Institute of New Jersey

    The Bronx, New York, United States

    Recruiting
  • the Ohio State University

    Columbus, Ohio, United States

    Recruiting
  • the University of Texas Md Anderson Cancer Center

    Houston, Texas, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Feb 2021
Primary completion
30 Nov 2023
Completion
15 Apr 2024
Last update posted
14 Mar 2023
Registered enrollment
45
Registry id
NCT04565275

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.